Lannett Company, Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages.
Read More…
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Phone215-333-9000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$655.41 million
Profitability
Miscellaneous
Employees1,020
Next Earnings Date5/4/2020 (Estimated)
OptionableOptionable
Lannett (NYSE:LCI) Frequently Asked Questions
What is Lannett's stock symbol?
Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."
How were Lannett's earnings last quarter?
Lannett Company, Inc. (NYSE:LCI) issued its earnings results on Wednesday, February, 5th. The company reported $0.27 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.27. The company earned $136.11 million during the quarter, compared to the consensus estimate of $128.60 million. Lannett had a positive return on equity of 18.75% and a negative net margin of 0.70%. The firm's revenue for the quarter was down 29.7% compared to the same quarter last year. During the same period last year, the business posted $0.32 EPS. View Lannett's Earnings History.
When is Lannett's next earnings date?
What guidance has Lannett issued on next quarter's earnings?
Lannett updated its FY 2020
After-Hours earnings guidance on Wednesday, February, 5th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $530-550 million, compared to the consensus revenue estimate of $536.21 million.
What price target have analysts set for LCI?
2 brokers have issued 1 year target prices for Lannett's stock. Their forecasts range from $14.00 to $14.00. On average, they expect Lannett's share price to reach $14.00 in the next year. This suggests a possible upside of 59.8% from the stock's current price. View Analyst Price Targets for Lannett.
What is the consensus analysts' recommendation for Lannett?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Lannett.
Has Lannett been receiving favorable news coverage?
News coverage about LCI stock has trended extremely negative recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Lannett earned a news sentiment score of -4.2 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Lannett.
Are investors shorting Lannett?
Lannett saw a decline in short interest in February. As of February 14th, there was short interest totalling 14,280,000 shares, a decline of 9.8% from the January 30th total of 15,830,000 shares. Based on an average daily volume of 1,010,000 shares, the days-to-cover ratio is currently 14.1 days. Approximately 45.5% of the shares of the company are short sold. View Lannett's Current Options Chain.
Who are some of Lannett's key competitors?
Some companies that are related to Lannett include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), The Medicines (MDCO), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR) and Pacira Biosciences (PCRX).
What other stocks do shareholders of Lannett own?
Who are Lannett's key executives?
Lannett's management team includes the folowing people:
- Mr. Timothy C. Crew, CEO & Director (Age 58)
- Mr. Martin P. Galvan, VP of Fin. & CFO (Age 67)
- Mr. Samuel H. Israel, Gen. Counsel & Chief Legal Officer (Age 57)
- Mr. John M. Abt, VP & Chief Quality Operations Officer (Age 54)
- Mr. John Kozlowski, Chief of Staff & Strategy Officer (Age 47)
Who are Lannett's major shareholders?
Lannett's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Telemus Capital LLC (19.04%), LSV Asset Management (5.16%), State Street Corp (3.21%), Renaissance Technologies LLC (3.20%), Public Sector Pension Investment Board (1.66%) and Prudential Financial Inc. (1.45%). Company insiders that own Lannett stock include Albert Paonessa III, Jeffrey Farber, Kevin Smith, Patrick G Lepore and Timothy C Crew. View Institutional Ownership Trends for Lannett.
Which major investors are selling Lannett stock?
LCI stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Connor Clark & Lunn Investment Management Ltd., Jacobs Levy Equity Management Inc., Telemus Capital LLC, Barclays PLC, IndexIQ Advisors LLC, Globeflex Capital L P and Man Group plc. View Insider Buying and Selling for Lannett.
Which major investors are buying Lannett stock?
LCI stock was acquired by a variety of institutional investors in the last quarter, including Public Sector Pension Investment Board, AJO LP, X Square Capital LLC, Credit Suisse AG, Massachusetts Financial Services Co. MA, Goldman Sachs Group Inc., AQR Capital Management LLC and Swiss National Bank. Company insiders that have bought Lannett stock in the last two years include Albert Paonessa III, Jeffrey Farber, Patrick G Lepore and Timothy C Crew. View Insider Buying and Selling for Lannett.
How do I buy shares of Lannett?
Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Lannett's stock price today?
One share of LCI stock can currently be purchased for approximately $8.76.
How big of a company is Lannett?
Lannett has a market capitalization of $353.41 million and generates $655.41 million in revenue each year. The company earns $-272,110,000.00 in net income (profit) each year or $2.35 on an earnings per share basis. Lannett employs 1,020 workers across the globe.View Additional Information About Lannett.
What is Lannett's official website?
How can I contact Lannett?
Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000.
MarketBeat Community Rating for Lannett (NYSE LCI)
MarketBeat's community ratings are surveys of what our community members think about Lannett and other stocks. Vote "Outperform" if you believe LCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCI will underperform the S&P 500 over the long term. You may vote once every thirty days.
